Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SMAD3 |
| Upstream (Parents) |
|---|
| (<<) SOX5 → SMAD3 |
| (<<) ASCL1 → SMAD3 |
| (<<) ATOH1 → SMAD3 |
| (<<) DMRT1 → SMAD3 |
| (<<) SPDEF → SMAD3 |
| (<<) ARNT2 → SMAD3 |
| (<<) ZNF117 → SMAD3 |
| (<<) HOXB6 → SMAD3 |
| (<<) SIX3 → SMAD3 |
| (<<) POU3F2 → SMAD3 |
| (<<) NKX6-1 → SMAD3 |
| (<<) NR2F1 → SMAD3 |
| (<<) DLX6 → SMAD3 |
| (<<) ZBTB17 → SMAD3 |
| (<<) THRB → SMAD3 |
| (<<) DBP → SMAD3 |
| Downstream (Children) |
|---|
| SMAD3 → ELF5 (>>) |
| SMAD3 → CITED1 (>>) |
| SMAD3 → BRD8 (>>) |
| SMAD3 → SIX1 (>>) |
| SMAD3 → ZNF81 (>>) |
| SMAD3 → PHOX2A (>>) |
